Synex Pharmaceuticals Pvt Ltd

Pharmaceutical company that manufactures, imports, and exports drugs and chemical preparations.

1984 | Mumbai, Maharashtra (India) | Active
Last Updated:

Synex Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 2.50 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 40 Year, 10 Months
  • Last Filing with ROC 31 Mar 2021
  • Open Charges ₹ 1.60 M
  • Satisfied Charges ₹ 1.38 Cr
  • Revenue Growth %
  • Profit Growth 80.64%
  • Ebitda 80.24%
  • Net Worth -0.80%
  • Total Assets -0.01%

About Synex Pharmaceuticals

Synex Pharmaceuticals Pvt Ltd (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 April 1984 and has a history of 40 years and ten months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M.

The company currently has active open charges totaling ₹1.60 M. The company has closed loans amounting to ₹1.38 Cr, as per Ministry of Corporate Affairs (MCA) records.

Hemant Gandhi and Hetal Sanghavi serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239MH1984PTC032614

  • Company No.

    032614

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    07 Apr 1984

  • Date of AGM

    30 Nov 2021

  • Date of Balance Sheet

    31 Mar 2021

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Synex Pharmaceuticals?

Board Members (2)

NameDesignationAppointment DateStatus
Hemant Gandhi Country flag representing In Director 07-Apr-1984Current
Hetal Sanghavi Country flag representing In Director 02-Jul-2003Current

Financial Performance of Synex Pharmaceuticals.

Synex Pharmaceuticals Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 80.64% increase in profit. The company's net worth dipped by a decrease of 0.8%.

Synex Pharmaceuticals revenue growth over time
Synex Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-0.01%
Profit or Loss
80.64%
Net Worth
-0.80%
EBITDA
80.24%

What is the Ownership and Shareholding Structure of Synex Pharmaceuticals?

In 2019, Synex Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹1.60 M

Satisfied Charges

₹13.84 M

Charges Breakdown by Lending Institutions

  • The Maharashtra Staet Financial Corp. : 0.14 Cr
  • State Bank Of India : 0.02 Cr

Latest Charge Details

DateLenderAmountStatus
25 Jul 1995State Bank Of India₹0.20 MOpen
14 Feb 1985The Maharashtra Staet Financial Corp.₹1.40 MOpen
05 Apr 1999State Bank Of India₹7.50 MSatisfied
06 Mar 1998State Bank Of India₹2.94 MSatisfied
06 Mar 1998State Bank Of India₹2.20 MSatisfied

How Many Employees Work at Synex Pharmaceuticals?

Unlock and access historical data on people associated with Synex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Synex Pharmaceuticals Pvt Ltd

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synex Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Synex Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Synex Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.

  • Balance Sheet

    Synex Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai.

  • Charges

    A charge registered on 05 Apr 1999 via Charge ID 90210973 with State Bank Of India was fully satisfied on 17 Nov 2006.

  • Charges

    A charge registered on 06 Mar 1998 via Charge ID 90210945 with State Bank Of India was fully satisfied on 17 Nov 2006.

  • Charges

    A charge registered on 06 Mar 1998 via Charge ID 90213148 with State Bank Of India was fully satisfied on 17 Nov 2006.

  • Charges

    A charge registered on 18 Oct 1996 via Charge ID 90212942 with State Bank Of India was fully satisfied on 17 Nov 2006.

Frequently asked questions

  • What is the Incorporation or founding date of Synex Pharmaceuticals Pvt Ltd?

    Synex Pharmaceuticals Pvt Ltd was incorporated on 07 Apr 1984.

  • What is authorized share capital and paid-up capital of Synex Pharmaceuticals Pvt Ltd?

    The authorized share capital of Synex Pharmaceuticals Pvt Ltd is ₹ 2.50 M and paid-up capital is ₹ 1.00 M.

  • Who are the current board members & directors of Synex Pharmaceuticals Pvt Ltd?

    Currently 2 directors are associated with Synex Pharmaceuticals Pvt Ltd.

    • Hemant Gandhi
    • Hetal Jay Sanghavi
  • What is the registered address of Synex Pharmaceuticals Pvt Ltd?

    As per Ministry of Corporate Affairs (Mca), the registered address of Synex Pharmaceuticals Pvt Ltd is 95/96 Abcd Government Industrial Estate Charkop, Kandivali (West) India, Mumbai, Maharashtra, 400067.

  • What is the corporate identification number (CIN) and company number of Synex Pharmaceuticals Pvt Ltd?

    The corporate identification number (CIN) of Synex Pharmaceuticals Pvt Ltd is U24239MH1984PTC032614 and the company number is 032614 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Synex Pharmaceuticals Pvt Ltd, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Synex Pharmaceuticals Pvt Ltd has experienced an downturn of -0.80%.

  • What are the total open charges for Synex Pharmaceuticals Pvt Ltd?

    As per the financial statements for fiscal Year 2020, The total open charges for Synex Pharmaceuticals Pvt Ltd amount to ₹ 1.60 M.

  • When was the last Balance Sheet of Synex Pharmaceuticals Pvt Ltd filed with the ROC?

    The most recent Balance Sheet for Synex Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2021.